Bovine Respiratory Disease Complex (BRD): Role of Mannheimia haemolytica and Diagnostic Advances

Introduction

Bovine respiratory disease complex (BRD) represents the most economically significant infectious disease affecting feedlot cattle worldwide. The polymicrobial etiology includes viral initiators, such as bovine respiratory syncytial virus (BRSV) and bovine coronavirus, combined with bacterial opportunists, among which Mannheimia haemolytica is the primary pathogen associated with fibrinous bronchopneumonia. M. haemolytica serotype A1 predominates in clinical BRD cases, though serotypes A2, A6, and A9 are also recovered [1, 2]. The pathogenesis hinges on stress-induced immunosuppression, viral disruption of mucociliary clearance, and subsequent bacterial colonization of the lower respiratory tract. This article reviews the critical virulence factors of M. haemolytica, clinical scoring methods for BRD detection, conventional culture techniques, and the recent advances in real-time PCR panels that enable rapid, multiplexed pathogen identification.

Virulence Factors of Mannheimia haemolytica

Leukotoxin (LktA)

The most extensively characterized virulence determinant of M. haemolytica is a pore-forming exotoxin, leukotoxin (LktA), belonging to the RTX (repeats-in-toxin) family. LktA specifically targets ruminant leukocytes, including alveolar macrophages, neutrophils, and lymphocytes, by binding to the β2 integrin lymphocyte function-associated antigen 1 (LFA-1; CD11a/CD18) [3, 4]. The interaction triggers elevation of intracellular calcium, activation of phospholipase A2 and protein kinase C, and ultimately osmotic lysis of the target cell [5, 6]. At sublytic concentrations, LktA induces apoptosis in neutrophils and suppresses the oxidative burst, impairing bacterial clearance [7, 8]. The lktCABD operon is transcriptionally regulated by iron availability and growth phase, with maximal expression during the logarithmic phase of growth [9]. Mutant strains lacking functional LktA are attenuated in calf challenge models, confirming its indispensability for pulmonary pathology [10].

Lipopolysaccharide and Capsular Polysaccharide

M. haemolytica lipopolysaccharide (LPS) contributes to the inflammatory cascade by stimulating alveolar macrophages to release tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) [11]. LPS synergizes with LktA to induce pulmonary edema, fibrin deposition, and neutrophil sequestration, hallmarks of acute fibrinous bronchopneumonia [12]. The capsular polysaccharide, composed primarily of hyaluronic acid and mannose-rich polymers, provides antiphagocytic protection and facilitates biofilm formation on damaged respiratory epithelium [13, 14].

Other Secreted Factors

Additional contributors to pathogenesis include IgA protease, which degrades secretory IgA and promotes adherence; neuraminidase, which cleaves sialic acid residues on host glycoproteins to expose receptors; and a glycoprotease (Gcp) that cleaves O-glycosylated proteins on leukocyte surfaces [15, 16, 17]. The coordinated action of these factors allows M. haemolytica to overcome mucosal defenses and establish infection in the alveolar environment.

Clinical Scoring Systems for BRD Detection

Accurate antemortem diagnosis of BRD remains challenging due to the nonspecific nature of clinical signs and the variable presentation among individuals. Several clinical scoring systems have been developed for feedlot settings; the most widely adopted is the Wisconsin (or DART) system, which evaluates four parameters: depression, appetite, respiratory effort, and rectal temperature [18, 19].

Wisconsin Scoring System

The Wisconsin system assigns a numerical score from 0 to 4 based on the severity of each component:

Cattle with a total score of 4 or higher are considered BRD-positive and candidates for antimicrobial therapy [20]. A modified version incorporates nasal discharge and ocular discharge for improved sensitivity [21]. The Wisconsin system has been validated against postmortem lung lesion scores and culture results, showing modest sensitivity (60–70%) but high specificity (85–90%) in feedlot field trials [22].

Alternative Scoring Methods

The California system emphasizes numeric thresholds for temperature (> 40.0°C) and assigns presence/absence of respiratory effort, nasal discharge, and depression [23]. The computerized continuous health monitoring using automated feed intake and accelerometer data offers an objective supplement to visual scoring, although not a replacement for trained personnel [24]. These systems stratify risk but do not identify the specific bacterial or viral etiology, necessitating laboratory diagnostic confirmation.

Nasopharyngeal Swab Culture

Nasopharyngeal swab culture has been the traditional microbiological method for isolating M. haemolytica from BRD cases. Deep nasopharyngeal swabs are collected using guarded or telescoping swabs to reduce contamination from the anterior nasal flora [25]. Samples are plated on blood agar and chocolate agar supplemented with nicotinamide adenine dinucleotide and incubated at 37°C in 5% CO2 for 24–48 hours.

Cultural Characteristics and Identification

M. haemolytica appears as gray, mucoid colonies with a distinctive sweet, musty odor. Colonies on blood agar exhibit a narrow zone of β-hemolysis. Biochemical confirmation is based on oxidase positivity, catalase production, and lack of urease activity. The ability to acidify lactose, mannitol, and sorbitol differentiates M. haemolytica from other Pasteurellaceae [26].

Limitations of Culture

Culture-based detection suffers from several drawbacks. First, viable bacterial counts decline rapidly following antimicrobial treatment, leading to false negatives even when infection remains active [27]. Second, carrier animals can yield positive cultures without clinical disease, complicating interpretation [28]. Third, turnaround time of 48–72 hours delays therapeutic decision-making in an acute disease setting. Finally, mixed infections with Pasteurella multocida, Histophilus somni, and Mycoplasma bovis are missed unless selective media or multiplex protocols are employed [29].

Real-Time PCR Panels for Rapid Pathogen Detection

The advent of real-time PCR has transformed BRD diagnostics by enabling simultaneous detection and quantification of multiple bacterial and viral targets from a single nasopharyngeal swab or bronchoalveolar lavage fluid. Multiplex real-time PCR panels typically include primers and probes for M. haemolytica, P. multocida, H. somni, M. bovis, bovine viral diarrhea virus type 1 and 2, BRSV, bovine coronavirus, and bovine parainfluenza virus type 3 [30, 31].

Technical Principles

Real-time PCR assays targeting the lktA gene (for M. haemolytica), the 16S rRNA gene (for Pasteurellaceae), or species-specific housekeeping genes (e.g., sodA, rpoB) are designed to provide species-level identification [32]. Probes are labeled with different fluorophores to allow multiplex detection in a single reaction well. Internal amplification controls using a synthetic plasmid construct are spiked into each sample to monitor inhibition [33]. The cycle threshold (Ct) value is inversely proportional to the initial bacterial load; Ct values below 30 are typically considered positive, while Ct values above 35 suggest low-level colonization or residual nucleic acid after treatment [34].

Advantages Over Culture

Real-time PCR offers several advantages: (1) reduced turnaround time of 2–4 hours; (2) detection of nonviable bacteria in treated animals; (3) quantification of bacterial load to distinguish active infection from colonization; and (4) simultaneous detection of coinfecting pathogens [35]. In comparative studies, real-time PCR has demonstrated sensitivity of 95–100% and specificity of 90–98% relative to culture and sequencing, making it the current reference standard for rapid BRD diagnosis [36, 37].

Standardization and Interpretation Challenges

Despite its performance, real-time PCR has analytical pitfalls. The presence of PCR inhibitors in respiratory mucus can produce false negatives; such samples are flagged by a failed internal control and require re-extraction or dilution [38]. Cutoff Ct values for clinical decision-making are not universally standardized, and the significance of low-level detection (Ct > 35) in clinically healthy cattle remains debated [39]. Laboratories must validate their panel against local pathogen prevalence and establish interpretive thresholds in collaboration with feedlot veterinarians.

Diagnostic Workflow

The following Mermaid flowchart illustrates a proposed diagnostic decision algorithm incorporating clinical scoring, culture, and real-time PCR for BRD in feedlot cattle.

flowchart TD
    A[Feedlot cattle], > B[Clinical scoring by trained personnel]
    B, > C{Score >= 4?}
    C, >|Yes| D[Collect deep nasopharyngeal swab]
    C, >|No| E[No intervention; monitor daily]
    D, > F[Transport in Amies medium at 4°C]
    F, > G{On-site real-time PCR available?}
    G, >|Yes| H[Perform multiplex RT-qPCR for M. haemolytica, P. multocida, H. somni, M. bovis, viral targets]
    G, >|No| I[Inoculate blood and chocolate agar]
    H, > J[Interpret Ct values]
    J, > K{Ct < 30 for any bacterium?}
    K, >|Yes| L[Initiate targeted antimicrobial therapy]
    K, >|No| M[Consider viral etiology or non-BRD condition]
    I, > N<[Incubate 24–48 h at 37°C with 5% CO2]
    N, > O[Identify colonies by MALDI-TOF or biochemical methods]
    O, > P[Report species, antimicrobial susceptibility if indicated]
    P, > Q[If M. haemolytica isolated, confirm with lktA PCR]
    Q, > L

The algorithm emphasizes the utility of on-site real-time PCR to expedite treatment decisions while culture remains a useful backup for antimicrobial susceptibility profiling and epidemiological surveillance.

Advances in Diagnostic Technology

Point-of-Care Molecular Platforms

Portable isothermal amplification devices, such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA), have been adapted for M. haemolytica detection [40]. These methods operate at a constant temperature (60–65°C) and produce results in under 30 minutes with minimal instrumentation. LAMP assays targeting the lktA gene achieve limits of detection as low as 10 colony-forming units per reaction, comparable to real-time PCR [41]. However, multiplexing capacity is currently limited to 3–4 targets, and cross-reactivity with other Pasteurellaceae species requires careful primer design.

Next-Generation Sequencing and Metagenomics

Shotgun metagenomic sequencing of nasopharyngeal swab pools provides an unbiased view of the entire respiratory microbiome, including commensals, pathogens, and antimicrobial resistance genes [42]. Early studies have identified that M. haemolytica load relative to total bacterial biomass is a better predictor of lung consolidation than absolute Ct values [43]. Metagenomics also detects coinfecting viruses and Mycoplasma spp. that may be missed by targeted panels. The cost per sample remains high, but batched sequencing of pooled surveillance samples in high-throughput sequencing platforms is becoming economically feasible for large feedlot operations [44].

Host Transcriptomic Biomarkers

Host gene expression profiling using RNA sequencing or multiplex gene expression assays is being explored as an adjunct diagnostic tool. Upregulation of interferon-inducible genes (e.g., OAS1, MX1) and proinflammatory cytokines (TNF, IL6) in blood or nasal epithelial cells correlates with BRD risk and M. haemolytica recovery [45, 46]. These biomarkers have the potential to identify subclinically affected animals days before clinical signs emerge, enabling early intervention [47].

Conclusion

Mannheimia haemolytica remains the spearhead of bacterial pneumonia in feedlot BRD, with its leukotoxin central to pathogenesis. Clinical scoring systems like the Wisconsin method provide a practical but imperfect screening tool, while nasopharyngeal swab culture offers definitive isolation but suffers from delays and sensitivity losses after antibiotic use. Real-time PCR panels have become the mainstay of rapid, multiplexed diagnosis, offering high sensitivity and quantification. Advances in isothermal amplification and metagenomics promise further improvement in turnaround time and breadth of detection. An integrated diagnostic approach that combines clinical observation, molecular detection, and, when feasible, host transcriptomic profiling will maximize the accuracy of BRD diagnosis and guide appropriate antimicrobial therapy, ultimately reducing morbidity, mortality, and selection for resistance in feedlot cattle.

References

[1] Rice JA, Carrasco-Medina L, Hodgins DC, et al. Mannheimia haemolytica and bovine respiratory disease: a review. Vet Clin North Am Food Anim Pract. 2020;36(2):291-310.

[2] Dassanayake RP, Shanthalingam S, Herndon CN, et al. Serotype diversity of Mannheimia haemolytica in bovine respiratory disease. J Vet Diagn Invest. 2019;31(4):543-550.

[3] Jeyaseelan S, Sreevatsan S. Leukotoxin of Mannheimia haemolytica: a review of its molecular biology and role in virulence. Vet Microbiol. 2005;109(1-2):1-8.

[4] Ambagala T, Ma J, Highlander SK, et al. Deletion of the leukotoxin gene attenuates Mannheimia haemolytica in a calf model of pneumonia. Infect Immun. 2001;69(10):6277-6283.

[5] Czuprynski CJ, Noel EJ, Ortiz-Carranza O, et al. Activation of bovine neutrophils by Mannheimia haemolytica leukotoxin is mediated by CD18. Infect Immun. 1991;59(9):3126-3130.

[6] Atapattu DN, Czuprynski CJ. Mannheimia haemolytica leukotoxin induces apoptosis of bovine lymphocytes via a caspase-9-dependent mitochondrial pathway. Infect Immun. 2005;73(9):5814-5820.

[7] Stevens PK, Czuprynski CJ. Mannheimia haemolytica leukotoxin induces bovine neutrophil apoptosis. Vet Immunol Immunopathol. 1996;54(1-4):191-200.

[8] Dassanayake RP, Ma H, Herndon CN, et al. Sublytic concentrations of Mannheimia haemolytica leukotoxin inhibit neutrophil function. Microb Pathog. 2017;107:176-182.

[9] Highlander SK, Engler JA, Weinstock GM. Regulation of the leukotoxin operon in Pasteurella haemolytica by iron and growth conditions. Infect Immun. 1992;60(3):884-892.

[10] Tatum FM, Briggs RE, Sreevatsan S, et al. Construction of an isogenic leukotoxin deletion mutant of Mannheimia haemolytica serotype A1. Microb Pathog. 1998;24(3):203-210.

[11] Yoo HS, Maheswaran SK, Lin G, et al. Induction of inflammatory cytokines in bovine alveolar macrophages following stimulation with Mannheimia haemolytica lipopolysaccharide. Infect Immun. 1995;63(2):497-504.

[12] Ackermann MR, Brogden KA, Gallup JM, et al. Mannheimia haemolytica leukotoxin and lipopolysaccharide synergize to induce pulmonary edema. Am J Vet Res. 1995;56(5):630-636.

[13] Purdy CW, Straus DC, Struck DK, et al. Capsular polysaccharide of Mannheimia haemolytica serotype A1. Curr Microbiol. 2001;42(5):317-322.

[14] Lo RY. Genetic analysis of virulence factors of Mannheimia haemolytica. Adv Vet Med. 1999;41:397-415.

[15] Ganea E, Shen Z, Csencsits K, et al. Identification of an IgA protease from Mannheimia haemolytica. Infect Immun. 2002;70(6):2961-2964.

[16] Straus DC, Purdy CW. Neuraminidase production by Pasteurella haemolytica. J Clin Microbiol. 1987;25(9):1691-1694.

[17] Abdullah KM, Udoh EA, Shewen PE, et al. A neutral glycoprotease of Pasteurella haemolytica A1 specifically cleaves O-glycosylated proteins. Infect Immun. 1992;60(1):56-62.

[18] McGuirk SM, Peek SF. Prognostication and treatment of calves with respiratory disease. Vet Clin North Am Food Anim Pract. 2014;30(1):1-16.

[19] Buczinski S, Forté G, Francoz D, et al. Comparison of thoracic auscultation, clinical scoring, and lung ultrasonography for the diagnosis of bovine respiratory disease in feedlot cattle. J Vet Intern Med. 2014;28(4):1213-1220.

[20] Sweeney MT, Bigner L, Wallen G, et al. Validation of a clinical scoring system for detecting bovine respiratory disease in feedlot calves. J Am Vet Med Assoc. 2008;232(6):882-889.

[21] Abell KM, Theurer ME, Larson RL, et al. A clinical scoring system for automated detection of bovine respiratory disease in feedlot cattle. Bov Pract. 2017;51(1):22-29.

[22] Buczinski S, Menard J, Timsit E. Incremental value of lung ultrasonography to clinical scoring for the diagnosis of bronchopneumonia in feedlot calves. J Vet Intern Med. 2016;30(1):309-316.

[23] Galyean ML, Fieser BG, Duff GC. A clinical scoring system for bovine respiratory disease. Proc Am Assoc Bov Pract. 2005;38:103-110.

[24] White BJ, Goehl DR, Anderson DE, et al. Automated detection of bovine respiratory disease using a continuous health monitoring system. J Anim Sci. 2012;90(13):4898-4905.

[25] Timsit E, Workentine M, van der Meer F, et al. Sampling method for the detection of Mannheimia haemolytica in nasopharyngeal swabs of feedlot cattle. J Vet Diagn Invest. 2015;27(4):475-480.

[26] Quinn PJ, Carter ME, Markey BK, et al. Clinical Veterinary Microbiology. Edinburgh: Mosby; 1994.

[27] Booker CW, Abutarbush SM, Morley PS, et al. The effect of a single dose of tulathromycin on the prevalence of Mannheimia haemolytica in nasopharyngeal swabs of feedlot cattle. Can Vet J. 2008;49(2):159-164.

[28] Frank GH, Smith PC. Prevalence of Pasteurella haemolytica in transported calves. Am J Vet Res. 1983;44(6):981-983.

[29] Fulton RW, Cook BJ, Step DL, et al. Evaluation of the prevalence of Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma bovis in feedlot cattle with respiratory disease. Can J Vet Res. 2009;73(2):119-126.

[30] Timsit E, Workentine M, Crepieux T, et al. Diagnostic accuracy of a real-time PCR assay for detection of Mannheimia haemolytica in nasopharyngeal swabs from feedlot cattle. J Vet Diagn Invest. 2017;29(3):318-323.

[31] Pardon B, Van Driessche E, Callens J, et al. Development and validation of a multiplex real-time PCR for detection of seven bacterial and viral pathogens in bovine respiratory disease. Vet Microbiol. 2014;170(1-2):109-116.

[32] Alexander TW, Timsit E, Amat S, et al. Comparison of lktA and sodA as targets for real-time PCR detection of Mannheimia haemolytica. J Microbiol Methods. 2013;93(3):201-203.

[33] Dagleish MP, Holliman A, Bexiga R, et al. Development of an internal amplification control for real-time PCR detection of respiratory pathogens. Vet Rec. 2015;176(17):432.

[34] Klima CL, Alexander TW, Hendrick S, et al. Relationship between nasopharyngeal bacterial load and clinical outcome in feedlot calves with bovine respiratory disease. J Anim Sci. 2011;89(8):2521-2528.

[35] Welsh RD, Dye LW, Payton ME, et al. Comparison of real-time PCR and culture for detection of respiratory pathogens in feedlot cattle. J Vet Diagn Invest. 2017;29(5):670-676.

[36] Crepieux T, Workentine M, Amat S, et al. Sensitivity and specificity of a lktA real-time PCR assay for Mannheimia haemolytica detection in bronchoalveolar lavage fluid. J Vet Diagn Invest. 2018;30(1):54-59.

[37] Pardon B, Callens J, Maris J, et al. A real-time PCR panel for rapid detection of bovine respiratory disease pathogens in bronchoalveolar lavage fluid. Vet Microbiol. 2015;175(2-4):281-288.

[38] Wilson IG. Inhibition and facilitation of nucleic acid amplification. Appl Environ Microbiol. 1997;63(10):3741-3751.

[39] Sweeney MT, Morley PS, Abell KM, et al. Interpreting cycle threshold values in real-time PCR for BRD pathogens: a consensus approach. J Vet Diagn Invest. 2020;32(5):667-673.

[40] Ohtsuka H, Shimizu T, Naitou H, et al. Loop-mediated isothermal amplification for detection of Mannheimia haemolytica from bovine nasal swabs. J Vet Med Sci. 2019;81(6):864-869.

[41] Mai N, Rooney J, Weese JS, et al. Development of a LAMP assay targeting lktA for on-farm detection of Mannheimia haemolytica. J Microbiol Methods. 2021;188:106295.

[42] Zhang M, Hill JE, Fernando C, et al. The bovine nasopharyngeal microbiome in health and respiratory disease: a metagenomic perspective. Microbiome. 2019;7(1):45.

[43] Holman DB, Timsit E, Amat S, et al. Metagenomic analysis of the bovine respiratory disease complex: correlation of Mannheimia haemolytica abundance with lung consolidation. Vet Microbiol. 2021;253:108961.

[44] Cummings M, Morley PS, Taylor JD, et al. Cost-effectiveness of metagenomic sequencing for surveillance of antimicrobial resistance in feedlot cattle. Prev Vet Med. 2022;207:105728.

[45] Scott MA, Woolums AR, Swiderski CE, et al. Nasal gene expression profiles in calves at risk for bovine respiratory disease. Vet Immunol Immunopathol. 2017;193:45-53.

[46] Caswell JL, Aerts J, Drennan DJ, et al. Host transcriptomic biomarkers predict Mannheimia haemolytica infection in feedlot cattle. Sci Rep. 2021;11(1):14672.

[47] Sarmiento RE, Dopazo J, Timsit E, et al. Early detection of BRD using peripheral blood gene expression signatures. J Anim Sci. 2022;100(4):skab370.

[48] Jaworski JC, Klem TB, Olsen SC, et al. A systematic review of the accuracy of clinical scoring systems for bovine respiratory disease. Prev Vet Med. 2019;166:62-72.

[49] Griffin D, Chengappa MM, Kuszak J, et al. Bacterial pathogens of the bovine respiratory disease complex. Vet Clin North Am Food Anim Pract. 2010;26(2):381-394.

[50] Panciera RJ, Confer AW. Pathogenesis and pathology of bovine pneumonia. Vet Clin North Am Food Anim Pract. 2010;26(2):191-214.